The metabolic syndrome: an emerging risk state for cardiovascular disease (Q35824621)

10 August 2017

1 reference

title

The metabolic syndrome: an emerging risk state for cardiovascular disease (English)

1 reference

10 August 2017

1 reference

Dorairaj Prabhakaran

1

0 references

author name string

Sonia S Anand

series ordinal

2

1 reference

10 August 2017

publication date

1 February 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

9

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

55-68

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Why can high insulin levels indicate a risk for coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Demonstration of insulin resistance in coronary artery disease documented with angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Insulin resistance and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Obesity, metabolic syndrome, and coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Emerging epidemic of cardiovascular disease in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Physical activity and the metabolic syndrome in a tri-ethnic sample of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Impact of weight loss on the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Weight, physical activity, and smoking as determinants of insulinemia in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Association of physical activity and visceral adipose tissue in older women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Smoking induces insulin resistance--a potential link with the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The risk of myocardial infarction is enhanced by a synergistic interaction between serum insulin and smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Smoking cessation improves insulin sensitivity in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Increased insulin concentrations in nondiabetic offspring of diabetic parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Insulin and Glucose Levels and Prevalence of Glucose Intolerance in Pedigrees With Multiple Diabetic Siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Familial Clustering of Insulin Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

In vivo insulin action is familial characteristic in nondiabetic Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Genetic influences on insulinemia in normotensive twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Adiponectin in a native Canadian population experiencing rapid epidemiological transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Obesity and its potential mechanistic basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Genetics of body-weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Fetal origins of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Fetal and infant growth and impaired glucose tolerance at age 64.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Fetal growth and impaired glucose tolerance in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Birth weight and adult hypertension, diabetes mellitus, and obesity in US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Size at birth, maternal weight, and type 2 diabetes in South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Birthweight and adult health outcomes in a biethnic population in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Fetal growth and cardiovascular risk factors in Jamaican schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Hypertriglyceridemia as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Adipose Tissue Lipoprotein Lipase and Hormone-Sensitive Lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Did grandma give you heart disease? The new battle against coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Insulin resistance and the metabolic syndrome-a challenge of the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Emergence of obesity and cardiovascular risk for coronary artery disease: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Visceral obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Differences in body mass index and waist: hip ratios in North Indian rural and urban populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Treatment of obesity: need to focus on high risk abdominally obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Renovascular hypertension and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Multivariate analysis of the relationship of six variables to blood pressure: Findings from Chicago Community Surveys, 1965–1971

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The epidemiology of impaired glucose tolerance and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Association of endogenous tissue plasminogen activator (t-PA) with clinical characteristics of the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Prospective study of endogenous tissue plasminogen activator and risk of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Insulin resistance and elevated levels of tissue plasminogen activator in first-degree relatives of South Asian patients with ischemic cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The role of TNF alpha in adipocyte metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Insulin resistance as the core defect in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Plasma adiponectin and endogenous glucose production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Regulation of adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Ambulatory blood pressure in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Elevated serum leptin concentrations in women with hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Insulin: in search of a syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Glycemic index in chronic disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Rationale for and role of thiazolidinediones in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Lessons from the glitazones: a story of drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

21 January 2018

Insulin secretagogues

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Ischaemic preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Incidence of non-melanocytic skin cancer treated in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Clinical practice. Aspirin for primary prevention of coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

Dysglycaemia and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X04VM515RA

10.1191/1358863X04VM515RA

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference